Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Swetha Rudraiah, Xi Zhang, Li Wang

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Nuclear receptors (NR) are ligand-modulated transcription factors that play diverse roles in cell differentiation, development, proliferation, and metabolism and are associated with numerous liver pathologies such as cancer, steatosis, inflammation, fibrosis, cholestasis, and xenobiotic/drug-induced liver injury. The network of target proteins associated with NRs is extremely complex, comprising coregulators, small noncoding microRNAs, and long noncoding RNAs. The importance of NRs as targets of liver disease is exemplified by the number of NR ligands that are currently used in the clinics or in clinical trials with promising results. Understanding the regulation by NR during pathophysiological conditions, and identifying ligands for orphan NR, points to a potential therapeutic approach for patients with liver diseases. An overview of complex NR metabolic networks and their pharmacological implications in liver disease is presented here.

Original languageEnglish (US)
Pages (from-to)605-626
Number of pages22
JournalAnnual Review of Pharmacology and Toxicology
StatePublished - Jan 6 2016


  • Cholestatic liver disease
  • Drug-induced liver injury
  • Hepatocellular cancer
  • Liver inflammation and fibrosis
  • Nonalcoholic fatty liver
  • Viral hepatitis infection

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?'. Together they form a unique fingerprint.

Cite this